Forecasting the future economic burden of current adolescent overweight: An estimate of the coronary heart disease policy model

American Journal of Public Health

Volumn 99, Issue 12, 2009, Pages 2230-2237

  Lightwood, James ^a   Bibbins Domingo, Kirsten ^a   Coxson, Pamela ^a   Wang, Y Claire ^a   Williams, Lawrence ^a   Goldman, Lee ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADOLESCENT; ARTICLE; DIABETES MELLITUS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OBESITY;

ADOLESCENT; ADULT; CORONARY DISEASE; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; OBESITY; UNITED STATES;

EID: 72249115424     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.152595     Document Type: Article

References (62)

1. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007; 357(23):2371-2379. (Pubitemid 350244535)
2. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics. 2005;115(1):22-27. (Pubitemid 43046277)
3. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Prev Med. 1993; 22(2):167-177. (Pubitemid 23150661)
4. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337(13): 869-873. (Pubitemid 27408568)
5. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity Among Adults in the United States-No Change Since 2003-2004. Hyattsville, MD: National Center for Health Statistics; 2007. NCHS Data Brief No 1.
6. Gaspoz JM, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346(23):1800-1806. (Pubitemid 34586917)
7. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277(7):535-542.
8. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987; 77(11):1417-1426. (Pubitemid 18011588)
9. Cholesterol Treatment Trialists' Collaborators. Ef- ficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet. 2005;366: 1267-1278.
10. West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 1998;97(15): 1440-1445.
11. Bibbins-Domingo K, Coxson P, Pletcher M, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease [supplementary appendix]. N Engl J Med. 2007;357(23):2371-2379. Available at: http://content.nejm.org/cgi/content/full/ 357/23/2371/DC1. Accessed August 28, 2008.
12. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002;246: 1-190.
13. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291(23):2847-2850.
14. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
15. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861-1867. (Pubitemid 40548182)
16. Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002;25(1):23-29. (Pubitemid 41070778)
17. Heidenreich PA, Davis BR, Cutler JA, et al. Costeffectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Gen Intern Med. 2008;23(5):509-516.
18. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19): 2542-2551.
19. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101(2):207-213.
20. Pignone M, Earnshaw S, Tice JA, Pletcher MJ. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med. 2006;144(5):326-336. (Pubitemid 46768187)
21. Clarke PM, Gray AM, Briggs A, et al. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia. 2005;48(5):868-877. (Pubitemid 40767979)
22. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
23. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854-865. (Pubitemid 28416719)
24. Gray A, Clarke P, Farmer A, Holman R, for the United Kingdom Prospective Diabetes Study (UKPDS) Group. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). BMJ. 2002;325:860. Available at: http://www.bmj.com/cgi/reprint/325/ 7369/860. Accessed August 25, 2008.
25. Hodgson TA, Cohen AJ. Medical expenditures for major diseases, 1995. Health Care Financ Rev. 1999; 21(2):119-164.
26. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med Care. 1999; 37(10):994-1012.
27. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey public use files. 1996-2001. 2004. Available at: http://www.meps. ahrq.gov/mepsweb/index.jsp. Accessed May 17, 2004.
28. Centers for Medicare and Medicaid Services. Personal health care spending by type of spending, age group, and source of payment distribution, calendar year 1999. 2000. Available at: http://www.cms.hhs.gov/ NationalHealthExpendData/ downloads/agetables.pdf. Accessed July 17, 2005.
29. Healthcare Quality and Analysis Division. California Patient Discharge Data, January 1-December 31, 2000, Public Version A-24. Sacramento, CA: California Office of Statewide Health Planning and Development; 2003.
30. California Office of Statewide Health Planning and Development, Healthcare Quality and Analysis Division. Hospital annual financial data, pivot profiles. 1999- 2000. 2003. Available at: http://www.oshpd.ca.gov/ HID/Products/Hospitals/AnnFinanData/PivotProfles/ default.asp. Accessed June 4, 2008.
31. Statistical Abstract of the United States, Average Cost to Community Hospitals per Patient, by State. Washington, DC: US Census Bureau; 1998: (Table 204).
32. Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health. 2005;26:239-257.
33. Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932.
34. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6(2):97-106.
35. US Census Bureau. Current Population Survey. Annual Social and Economic (ASEC) Supplement: PINC- 01. Selected characteristics of people 15 years and over by total money income in 2006, work experience in 2006, race, Hispanic origin, and sex (male). 2007. Available at: http://pubdb3.census.gov/macro/ 032007/perinc/new01-010.htm. Accessed July 21, 2008.
36. US Census Bureau. Current Population Survey. Annual Social and Economic (ASEC) Supplement: PINC- 01. Selected characteristics of people 15 years and over by total money income in 2006, work experience in 2006, race, Hispanic origin, and sex (female). 2007. Available at: http://pubdb3.census.gov/macro/ 032007/perinc/new01-019.htm. Accessed July 21, 2008.
37. Bureau of Labor Statistics. National Compensation Survey. Employer cost for employee compensation (NAICS basis). 2008. Available at: http://www.bls.gov/ ncs/home.htm#data. Accessed July 21, 2008.
38. Drewnowski A. The real contribution of added sugars and fats to obesity. Epidemiol Rev. 2007;29:160-171. (Pubitemid 47229647)
39. Rosin O. The economic causes of obesity: a survey. J Econ Surv. 2008;22(4):617-647.
40. Edge RM, Laubach T, Williams JC. Learning and shifts in long-run productivity growth. J Monet Econ. 2007;54:2421-2438.
41. Bureau of Labor Statistics. Current Population Survey. Unemployment statistics. 2008 Available at: http://www.bls.gov/cps/home.htm. Accessed July 17, 2008.
42. Tunceli K, Li K, Williams LK. Long-term effects of obesity on employment and work limitations among U.S. Adults, 1986 to 1999. Obesity (Silver Spring). 2006; 14(9):1637-1646.
43. Yassin AS, Beckles GL, Messonnier ML. Disability and its economic impact among adults with diabetes. J Occup Environ Med. 2002;44(2):136-142. (Pubitemid 34142972)
44. Finkelstein E, Fiebelkorn C, Wang G. The costs of obesity among full-time employees. Am J Health Promot. 2005;20(1):45-51.
45. Gregg EW, Beckles GL, Williamson DF, et al. Diabetes and physical disability among older U.S. adults. Diabetes Care. 2000;23(9):1272-1277. (Pubitemid 30683131)
46. Cawley J, Rizzo J, Haas K. The association of diabetes with job absenteeism costs among obese and morbidly obese workers. J Occup Environ Med. 2008;50(5):527-534. (Pubitemid 351677635)
47. Månsson NO, Eriksson KF, Israelsson B, Ranstam J, Melander A, Råstam L. Body mass index and disability pension in middle-aged men-non-linear relations. Int J Epidemiol. 1996;25(1):80-85. (Pubitemid 26060273)
48. Hawkes AL, Nowak M, Bidstrup B, Speare R. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag. 2006;2(4):477-484. (Pubitemid 46231277)
49. Mital A, Desai A, Mital A. Return to work after a coronary event. J Cardiopulm Rehabil. 2004;24(6): 365-373.
50. Perk J, Alexanderson K. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 8. Sick leave due to coronary artery disease or stroke. Scand J Public Health Suppl. 2004;63:181-206.
51. Reynolds MW, Frame D, Scheye R, et al. A systematic review of the economic burden of chronic angina. Am J Manag Care. 2004;10(11 Suppl):S347-S357.
52. Samkange-Zeeb F, Altenhoner T, Berg G, Schott T. Predicting non-return to work in patients attending cardiac rehabilitation. Int J Rehabil Res. 2006;29(1): 43-49. (Pubitemid 44378301)
53. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003- 2006. JAMA. 2008;299(20):2401-2405.
54. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S74-S80.
55. Smith SA, Hulsey T, GoodnightW. Effects of obesity on pregnancy. J Obstet Gynecol Neonatal Nurs. 2008; 37(2):176-184.
56. Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L. The impact of obesity on the musculoskeletal system. Int J Obes. 2008;32:211-222.
57. Malhotra A, Hillman D. Obesity and the lung: 3. Obesity, respiration and intensive care. Thorax. 2008; 63:925-931.
58. Sin DD, Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax. 2008;63:1018-1023.
59. Dennis KE. Postmenopausal women and the health consequences of obesity. J Obstet Gynecol Neonatal Nurs. 2007;35(5):511-1117
60. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol. 2008;294:F685-F696.
61. Crummy F, Piper A, Naughton M. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax. 2008;63:738-746.
62. Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63:1110-1117.